Popular supplement creatine supercharges critical immune cells fighting cancer
Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical…
Gounder Fills In Details Behind Ebola, GLP-1, and Trump Headlines
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed a recent study that suggests ultraprocessed foods are…
Researchers challenge the traditional understanding of how histone deacetylase inhibitors function
Researchers at Baylor College of Medicine and collaborating institutions are challenging the traditional understanding of how cancer drugs…
Study validates research models for tracking circular extra-chromosomal DNA
Damage to DNA in cancer cells can lead to pieces breaking off chromosomes and floating away, like icebergs…
Fast food is crowding out grocery access across the U.S.
A nationwide study reveals how US neighborhoods became increasingly dominated by restaurants and fast-food outlets, leaving millions with…
Kate Middleton visits cancer patients undergoing chemotherapy
Kate, the Princess of Wales, is continuing her work to support people affected by cancer with a visit…
Novel technology maps single-cell DNA-protein interactions
A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and…
Blood protein signature can predict lung cancer risk before diagnosis
Researchers at the Francis Crick Institute and University College London (UCL), funded by Cancer Research UK and the…
Weight-loss drugs may cut breast cancer risk by up to 30%, study finds
Women who take GLP-1 medications, such as Ozempic or Mounjaro, are less likely to develop breast cancer, a…
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can…
Could GLP-1 drugs help prevent breast cancer? New study points to a possible link
A major breast imaging study links GLP-1 agonists to lower breast cancer incidence, raising hopes for a new…
Study potentially opens a new route to more selective cancer drug design
Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in…